NCT03353688View on ClinicalTrials.gov

Biomarkers to Guide Directional DBS for Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

August 15, 2022

Study Completion Date

July 31, 2024

Conditions
Parkinson Disease
Interventions
DEVICE

Boston Scientific Vercise PC IPG with directional DBS lead

Deep brain stimulation

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT03353688 - Biomarkers to Guide Directional DBS for Parkinson's Disease | Biotech Hunter | Biotech Hunter